UK markets close in 4 hours 37 minutes

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
143.05-0.36 (-0.25%)
At close: 04:00PM EST
144.07 +1.02 (+0.71%)
Pre-market: 05:55AM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
18,564,800
18,976,700
482,325
108,589
Cost of revenue
4,693,400
3,860,700
704,362
243,827
Gross profit
13,871,400
15,116,000
-222,037
-135,238
Operating expenses
Research development
-
-
2,033
226,466
Selling general and administrative
548,200
328,900
101,424
43,410
Total operating expenses
457,700
200,100
-132,618
46,280
Operating income or loss
13,413,700
14,915,900
-89,419
-181,518
Interest expense
17,500
5,400
2,003
1,718
Total other income/expenses net
1,106,200
156,300
-52,896
2,341
Income before tax
14,495,400
15,046,400
-145,802
-179,440
Income tax expense
4,173,500
4,753,900
-161,000
-268
Income from continuing operations
10,321,900
10,292,500
15,198
-179,172
Net income
10,321,900
10,292,500
15,198
-179,056
Net income available to common shareholders
10,321,900
10,292,500
15,198
-179,056
Basic EPS
-
42.18
0.06
-0.85
Diluted EPS
-
39.63
0.06
-0.85
Basic average shares
-
244,000
253,300
212,057
Diluted average shares
-
259,700
253,300
212,057
EBITDA
-
15,127,000
-105,055
-143,826